Acta Vet. Brno 2017, 86: 399-404
https://doi.org/10.2754/avb201786040399
Improvement of colitis by Lactobacillus plantarum LS/07 and inulin
References
1. I, Atreya R, Neurath MF 2008: NF-kappaB in inflammatory bowel disease. J Intern Med 263: 591-596
<https://doi.org/10.1111/j.1365-2796.2008.01953.x>
2. IA, König A, Allenspach K, Sauter SN, Boisclair J, Doherr MG, Jungi TW 2008: Upregulation of toll-like receptors in chronic enteropathies in dogs. J Vet Intern Med 22: 553-560
<https://doi.org/10.1111/j.1939-1676.2008.0093.x>
3. M, Spaterna A, Laus F, Tesci B, Rossi G, Antonelli E, Villanacci V, Bassotti G 2010: Inflammatory bowel diseases in the dog: Differences and similarities with humans. World J Gastroenterol 16: 1050-1056
<https://doi.org/10.3748/wjg.v16.i9.1050>
4. E, Szabadosova V, Štofilová J, Salaj R, Bomba A 2014: Inulin diet intervention on chemopreventive and inflammatory markers in tumorigenesis of colorectal cancer. Acta Veterinaria-Beograd 64: 519-525
5. R, Scobey M, Cheng J 2014: The risk of colon cancer in inflammatory bowel disease. J Gastroin Dig Sys 4: 1-3
6. J, Zdunczyk Z, Wroblewska M, Oszmianski J, Hernandez T 2002: The responce of rats to feeding with diets containing grapefruit flavonoid extract. Food Res Int 35: 201-205
<https://doi.org/10.1016/S0963-9969(01)00184-3>
7. KA 2009: Inflammatory bowel disease in horses. Vet Clin North Am Equine Pract 25: 303-315
<https://doi.org/10.1016/j.cveq.2009.04.008>
8. M, Kenudson MM, Mizoguchi E 2011: Animal models of colitis-associated carcinogenesis. J Biomed Biotechnol 2011: ID 342637, 1-23
<https://doi.org/10.1155/2011/342637>
9. X, Mei Q, Xu J, Hu J 2009: Balsalazine decreases intestinal mucosal permeability of dextran sulfate sodium-induced colitis in mice. Acta Pharmacol Sin 30: 987-993
<https://doi.org/10.1038/aps.2009.77>
10. MAC, Dieleman LA 2009. Prebiotic in chronic intestinal inflammation. Inflamm Bowel Dis 15: 454-462
<https://doi.org/10.1002/ibd.20737>
11. N, Hall JA, Gaschen F, Forster U, Wenzlow N, Hermann P, Allenspach K, Dobbelaere D, Burgener IA, Welle M 2010: Activation of nuclear factor kappa B in dogs with chronic enteropathies. Vet Immunol Immunopathol 133: 228-236
<https://doi.org/10.1016/j.vetimm.2009.08.014>
12. DR 2011: Probiotics in inflammatory bowel diseases and associated conditions. Nutrients 3: 245-264
<https://doi.org/10.3390/nu3020245>
13. I, Tijjani BM, Wani H, Hassan NS, Khan AB, Hussain S 2011: Biomarkers in the management of ulcerative colitis: a brief review. German Medical Science 9: 1-7
14. C, Ding A 2011: Nonresolving inflammation. Cell 140: 871-882
<https://doi.org/10.1016/j.cell.2010.02.029>
15. B, Ali M, Forghani R, Schob S, Hsieh KLC, Wojtkiewicz G, Linnoila JJ, Chen JW 2013: Measuring myeloperoxidase activity in biological samples. PLOS One 8: 1-10
<https://doi.org/10.1371/journal.pone.0067976>
16. L, Bomba A, Hijová E, Chmelárová A, Mojžišová G, Bertková I, Koprovičová J, Pomfy M, Strompfová V, Molokáčová M 2011: Effects of probiotic in combination with prebiotics on intestinal lactobacilli and coliforms and activities of bacterial enzymes in 1,2-dimethylhydrazine exposed rats. Czech J Anim Sci 56: 99-106
<https://doi.org/10.17221/56/2010-CJAS>
17. V, Brocolli M, Ursino MG, Canistro D, Valgimigli L, Soleti A, Paolini M, DePonti F 2010: Non-peptidyl low molecular weight radical scavenger IAC attenuates DSS-induced colitis in rats. World J Gastroenterol 16: 3642-3650
<https://doi.org/10.3748/wjg.v16.i29.3642>
18. EC, Lucak S 2010: Use of probiotics in gastrointestinal disorders: what to recommend? Therap Adv Gastroenterol 3: 307-319
<https://doi.org/10.1177/1756283X10373814>
